![Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO](https://www.esmo.org/var/esmo/storage/images/esmo/esmo-staff/impakt-prep/impakt-2015-news/abstract-39o-impakt-2015/1137949-1-eng-GB/Abstract-39O-IMPAKT-2015_i1200.jpg)
Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO
![PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dbd4fbdf-ffaa-4636-b28c-91ec672c29f4/gr1_lrg.jpg)
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology
![Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bec8d922-387f-45c5-8689-b81767fac1ec/gr1.jpg)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology
![PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657 PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657](https://image3.slideserve.com/5807657/slide1-l.jpg)
PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657
![Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12d0e658-a40b-400e-996f-87549adc4f14/gr1.jpg)
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine
![Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523316300821-gr1.jpg)
Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect
![Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond - Zubarayev - Translational Gastroenterology and Hepatology Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond - Zubarayev - Translational Gastroenterology and Hepatology](https://cdn.amegroups.cn/journals/tgh/files/journals/26/articles/5274/public/5274-PB4-8697-R1.png)
Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond - Zubarayev - Translational Gastroenterology and Hepatology
![Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society](https://erj.ersjournals.com/content/erj/56/suppl_64/4493/F1.large.jpg)
Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society
![CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040235700/2053766526/gr1.jpg)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology
![Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/908408/f/1.png)
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for
![Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031302520310060-gr1.jpg)
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
![Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | British Journal of Cancer Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.bjc.6601020/MediaObjects/41416_2003_Article_BF6601020_Fig1_HTML.gif)
Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | British Journal of Cancer
PLOS ONE: The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
![Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker. | Semantic Scholar Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f8c61b10902fc44c7feba306cd34f4528da22dd0/3-Table1-1.png)